Business News, stay in the loop
Milestones, appointments, partnerships, investors & more
Praetura Ventures leads £2.9m investment in food allergy diagnostic firm
Praetura Ventures leads £2.9m investment in food allergy diagnostic firm Posted on July 14, 2021 Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a business that is on course to transform the food allergy diagnostics market....
UK Food Allergy Diagnostic company, Reacta Biotech, achieves MHRA GMP licence
UK Food Allergy Diagnostic company, Reacta Biotech, achieves MHRA GMP licence Posted on June 16, 2021 Pursuant to a capital raise in 2020, Reacta has achieved its goal of securing an MHRA site license This license opens up significant opportunities for the companies...
Reacta Biotech making progress on peanut diagnostic product
Reacta Biotech making progress on peanut diagnostic product Posted on May 19, 2020Deeside-based Reacta Biotech is on course to secure a market authorisation for its peanut diagnostic product within the next two years as global activity to treat peanut allergies...
Reacta Healthcare Awarded Major Biomedical Catalyst Grant to develop Paediatric Food allergy diagnostics
Reacta Healthcare Awarded Major Biomedical Catalyst Grant to develop Paediatric Food allergy diagnostics Posted on April 27, 2022 The £1 million grant will support the development of the first Oral Food Challenges (OFCs) for paediatric patients to diagnose...
UK food allergy diagnostic company, Reacta Biotech raises £1.25m to continue expansion plans
UK food allergy diagnostic company, Reacta Biotech raises £1.25m to continue expansion plans Posted on April 21, 2020 Reacta Biotech raises £1.25m to secure MHRA site license Once achieved, the license will enable significantly expanded production of its Oral Food...